Related Articles

• Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
• The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway
• Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation
• Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditions
• Immunoactivative role of indoleamine 2,3‑dioxygenase in gastric cancer cells in vitro